157182-23-5
157182-23-5 structure
- Name: Metesind glucuronate
- Chemical Name: Metesind glucuronate
- CAS Number: 157182-23-5
- Molecular Formula: C23H24N4O3SC6.H10O7
- Molecular Weight: 630.666
- Create Date: 2020-01-20 11:30:56
- Modify Date: 2024-09-14 23:54:13
-
Metesind glucuronate (AG 331;AG-265 glucuronate) is a potent thymidylate synthase (TS) inhibitor with IC50/IC90 of 0.7/3.0 uM; inhibits the cofactor binding site of TS, and accumulates in the S phase of the cell cycle in H35 cells at 10 uM. Brain Cancer Discontinued
| Name | Metesind glucuronate |
|---|---|
| Synonyms |
4-((4-(((2-Aminobenz[cd]indol-6-yl)methylamino)methyl)phenyl)sulfonyl)morpholine mono-D-Glucuronate
Benz[cd]indole-2,6-diamine, N6-methyl-N6-[[4-(4-morpholinylsulfonyl)phenyl]methyl]-, compd. with β-D-glucopyranuronic acid (1:1) N6-Methyl-N6-[4-(4-morpholinylsulfonyl)benzyl]benzo[cd]indole-2,6-diamine - β-D-glucopyranuronic acid (1:1) 4-((a-((2-Aminobenz[cd]indol-6-yl)methylamino)-p-tolyl)sulfonyl)morpholine mono-D-Glucuronate Metesind glucuronate N6-methyl-N6-[4-(morpholin-4-ylsulfonyl)benzyl]benzo[cd]indole-2,6-diamine - β-D-glucopyranuronic acid (1:1) |
| Description | Metesind glucuronate (AG 331;AG-265 glucuronate) is a potent thymidylate synthase (TS) inhibitor with IC50/IC90 of 0.7/3.0 uM; inhibits the cofactor binding site of TS, and accumulates in the S phase of the cell cycle in H35 cells at 10 uM. Brain Cancer Discontinued |
|---|---|
| References | References 1. Pressacco J, et al. Cancer Res. 1995 Apr 1;55(7):1505-8. 2. O'Connor BM, et al. Cancer Chemother Pharmacol. 1994;34(3):225-9. 3. Panadero A, et al. Oncol Res. 1995;7(2):73-81. View Related Products by Target Nucleoside Antimetabolite/Analog Brain Cancer |
| Molecular Formula | C23H24N4O3SC6.H10O7 |
|---|---|
| Molecular Weight | 630.666 |
| Exact Mass | 630.199585 |